NewAmsterdam Pharma Co N.V.
Public company- Headquarters
- NARRDEN
- Ticker
- NAMS
- CIK
- 0001936258
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| COODouglas Kling | Aug 14, 2026 | Departed |
| principal accounting officerRobert W. Gunning | Aug 14, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- TEVA PHARMACEUTICAL INDUSTRIES LTD
WARN notice: Fairfield, NJ
- NOVARTIS AG
WARN notice: East Hanover, NJ
- IMMUNIC, INC.
member of the Board of Directors departs: Duane Nash
- Executive departure
COO departs: Douglas Kling
Douglas Kling, Chief Operating Officer of NewAmsterdam Pharma Co N.V., resigns the role, effective August 14, 2026. The company reported the change in an 8-K/A that cites Item 5.02.
Source: SEC 8-K, filed Aug 14, 2026Role: Chief Operating Officer
- Executive appointment
principal accounting officer appointed: Robert W. Gunning
Robert W. Gunning was named principal accounting officer of NewAmsterdam Pharma Co N.V., effective August 10, 2026. Robert W. Gunning succeeds Louise Kooij. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 14, 2026Role: principal accounting officer
- Executive departure
principal accounting officer departs: Louise Kooij
Louise Kooij, principal accounting officer of NewAmsterdam Pharma Co N.V., departs the role, effective August 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 14, 2026Role: principal accounting officer
Last verified Nov 8, 2026